Literature DB >> 16426998

Sodium channels and mechanisms of neuropathic pain.

Marshall Devor1.   

Abstract

UNLABELLED: Na+ channels are large transmembrane proteins with a voltage-gated central pore capable of selectively passing Na+ ions. They are critical determinants of the electrical excitability of sensory neurons and play a key role in pain sensation by controlling afferent impulse discharge. Injury and disease affecting peripheral nerves induces axonopathy and demyelination. These neuropathic changes, in turn, trigger membrane remodeling in injured afferents and perhaps also in uninjured neighbors. A major consequence of the remodeling is increased cellular excitability. This is due in large part to subtype-selective abnormalities in the expression and trafficking of Na+ channels and perhaps also to altered kinetic properties of unitary channels. Hyperexcitable neurons show enhanced membrane resonance, rhythmogenesis, and ectopic spiking. The resulting excess discharge constitutes a primary neuropathic pain signal. In addition, it triggers and maintains central sensitization. This amplifies residual afferent input, yielding tactile allodynia, and it also amplifies ongoing ectopia that exaggerates spontaneous pain. Membrane-stabilizing Na+ channel ligands suppress neuropathic pain by selectively reducing membrane resonance in injured afferents and hence ectopic hyperexcitability. The clinical usefulness of these peripherally acting drugs might be enhanced by reducing their central side effects. PERSPECTIVE: Neuropathic pain is a complex outcome of multiple pathophysiological changes that develop in the peripheral nervous system (PNS) and the central nervous system (CNS) following nerve injury or disease. All or most of the CNS changes are thought to be due to abnormal signaling from the PNS, notably electrical hyperexcitability of peripheral sensory neurons. Because hyperexcitability is associated with abnormal sodium channel regulation, this process is a prime target for therapeutic intervention.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16426998     DOI: 10.1016/j.jpain.2005.09.006

Source DB:  PubMed          Journal:  J Pain        ISSN: 1526-5900            Impact factor:   5.820


  104 in total

1.  PKA-induced internalization of slack KNa channels produces dorsal root ganglion neuron hyperexcitability.

Authors:  Megan O Nuwer; Kelly E Picchione; Arin Bhattacharjee
Journal:  J Neurosci       Date:  2010-10-20       Impact factor: 6.167

2.  Morphological and functional changes in guinea-pig neurons projecting to the ileal mucosa at early stages after inflammatory damage.

Authors:  Kulmira Nurgali; Zhengdong Qu; Billie Hunne; Michelle Thacker; Louise Pontell; John B Furness
Journal:  J Physiol       Date:  2010-11-22       Impact factor: 5.182

3.  Fragile X mental retardation protein (FMRP) and the spinal sensory system.

Authors:  Theodore J Price; Ohannes K Melemedjian
Journal:  Results Probl Cell Differ       Date:  2012

4.  Continuous infusion of the cannabinoid WIN 55,212-2 to the site of a peripheral nerve injury reduces mechanical and cold hypersensitivity.

Authors:  I J Lever; T M Pheby; A S C Rice
Journal:  Br J Pharmacol       Date:  2007-03-20       Impact factor: 8.739

Review 5.  "Listening" and "talking" to neurons: implications of immune activation for pain control and increasing the efficacy of opioids.

Authors:  Linda R Watkins; Mark R Hutchinson; Erin D Milligan; Steven F Maier
Journal:  Brain Res Rev       Date:  2007-07-13

6.  New index of pain triggered by spinal activation of voltage-dependent sodium channels.

Authors:  Ryugo Enomoto; Mina Tsukamoto; Yukinori Shimoshige; Toshiaki Aoki; Nobuya Matsuoka
Journal:  J Anesth       Date:  2013-06-13       Impact factor: 2.078

Review 7.  Neuropathic Pain: Central vs. Peripheral Mechanisms.

Authors:  Kathleen Meacham; Andrew Shepherd; Durga P Mohapatra; Simon Haroutounian
Journal:  Curr Pain Headache Rep       Date:  2017-06

8.  MMPs initiate Schwann cell-mediated MBP degradation and mechanical nociception after nerve damage.

Authors:  Hideo Kobayashi; Sharmila Chattopadhyay; Kinshi Kato; Jennifer Dolkas; Shin-Ichi Kikuchi; Robert R Myers; Veronica I Shubayev
Journal:  Mol Cell Neurosci       Date:  2008-09-05       Impact factor: 4.314

9.  Ranolazine attenuates behavioral signs of neuropathic pain.

Authors:  Harry J Gould; Colleen Garrett; Renee R Donahue; Dennis Paul; Ivan Diamond; Bradley K Taylor
Journal:  Behav Pharmacol       Date:  2009-12       Impact factor: 2.293

10.  Placebo and Active Treatment Additivity in Placebo Analgesia: Research to Date and Future Directions.

Authors:  Matthew J Coleshill; Louise Sharpe; Luana Colloca; Robert Zachariae; Ben Colagiuri
Journal:  Int Rev Neurobiol       Date:  2018-08-06       Impact factor: 3.230

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.